GENI Stock Tickeron detected bearish Stock Pattern: Three Falling Peaks GENI on December 22, 2025, netting in a 5.28% gain over 3 weeks

GET DAILY SIGNALS

Get AI intraday signals

GENI - Genius Sports Limited

Ticker: GENI

Company: Genius Sports

Gain from shorting: +5.28%

Confirmed: 12/22/25

Succeeded: 01/12/26

Total length: 24 days

On December 19, 2025, A.I.dvisor detected a Three Falling Peaks Pattern (Bearish) for Genius Sports Limited (GENI, $10.80). 3 days later, on December 22, 2025, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On January 12, 2026, the stock hit the target price of $10.00 – resulting in a gain for traders who shorted the stock on the pattern detection date.

GENI sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for GENI moved below the 200-day moving average on December 16, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for GENI moved out of overbought territory on December 31, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GENI as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GENI turned negative on January 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

GENI moved below its 50-day moving average on January 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GENI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GENI broke above its upper Bollinger Band on December 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for GENI crossed bullishly above the 50-day moving average on December 19, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GENI advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GENI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.271) is normal, around the industry mean (36.517). P/E Ratio (0.000) is within average values for comparable stocks, (55.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (24.431). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (4.049) is also within normal values, averaging (32.562).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GENI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.